Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RBM7 regulates breast cancer progression

ABSTRACT: RBM7 regulates breast cancer progression

PROVIDER: PRJNA1046479 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26991476_1.fastq.gz	Fastqsanger.gz
	SRR26991476_2.fastq.gz	Fastqsanger.gz
	SRR26991477_1.fastq.gz	Fastqsanger.gz
	SRR26991477_2.fastq.gz	Fastqsanger.gz
	SRR26991478_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RBMS1 regulates breast cancer progression

Project description:RBMS1 regulates breast cancer progression

| PRJNA759645 | ENA

RBM4 regulates esophageal cancer progression

Project description:RBM4 regulates esophageal cancer progression

| PRJNA798399 | ENA

RBM4 regulates lung cancer progression

Project description:RBM4 regulates lung cancer progression

| PRJNA800104 | ENA

RBMS1 regulates lung cancer progression

Project description:RBMS1 regulates lung cancer progression

| PRJNA720396 | ENA

MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression

Project description:MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression

| PRJNA596185 | ENA

CCDC12 regulates selective shear of RBM47 to promote breast cancer progression

Project description:CCDC12 regulates selective shear of RBM47 to promote breast cancer progression

| PRJNA1111071 | ENA

AIB1D4 role in early breast cancer progression

Project description:AIB1D4 role in early breast cancer progression

| PRJNA578942 | ENA

NEK2 regulates triple negative breast cancer transcriptome.

Project description:NEK2 regulates triple negative breast cancer transcriptome.

| PRJNA590988 | ENA

The RNA-binding protein RBM47 suppresses metastatic breast cancer progression

Project description:Through integrative analysis of clinical breast cancer gene expression datasets, cell line models of breast cancer progression, and mutation data from cancer genome resequencing studies, we have identified RNA binding motif protein 47 (RBM47) as a candidate suppressor of breast cancer metastasis. RBM47 inhibited breast cancer progression in experimental models. Transcriptome-wide analysis of RBM47 localization by HITS-CLIP revealed widespread binding to mRNAs, preferentially at the 3' UTRs. RBM47 altered the abundance of a subset of its target mRNAs. Some of the mRNAs stabilized by RBM47, as exemplified by dickkopf WNT signaling pathway inhibitor 1 (DKK1), mediate tumor suppressive effects downstream of RBM47. This work identifies RBM47 as a suppressor of breast cancer progression and highlights the potential of global RNA modulatory events as a source of metastasis-promoting phenotypic traits. Cancer cells transduced with doxycycline-inducible wildtype RBM47 or the RBM47-I281fs mutant, treated with increasing concentrations of doxycycline.

2014-06-11 | E-GEOD-53779 | biostudies-arrayexpress

PTHrP regulates fatty acid metabolism via novel lncRNA in breast cancer initiation and progression models

Project description:The 5-year survival rate for women with metastatic breast cancer is 29%. Potential biomarkers identification is important for new therapeutic treatment in affected patients. Previous studies have shown that Parathyroid hormone-related peptide (PTHrP) plays a critical role in breast cancer growth and metastasis. The aim of our study was to use a genetically modified breast cancer mouse model to precisely examine the role of PTHrP from early primary breast cancer initiation to late progression. We identified a novel lncRNA, a new target for fatty acid metabolism that can be regulated by PTHrP in our unique mouse breast cancer model. We confirmed that a potential human lncRNA, OLMALINC, plays a similar role in fatty acid metabolism that can be regulated by PTHrP. Therefore, we validated our mouse finding in the human breast cancer cell lines. Genetically engineered mouse models provide valuable tools to study the molecular progression for breast cancer metastasis.

2023-12-30 | GSE225877 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data